Differences in Bacterial Species and Their Resistance Rates based on Sputum Cultures between Tertiary Hospitals and Smaller Medical Institutions.
10.12771/emj.2013.36.2.126
- Author:
Tae Hyung KIM
1
;
Kyung Pyo CHO
;
Jae Sung LEE
;
Yong Moon WOO
;
Ji Seok SEONG
;
Chang Suk NOH
Author Information
1. Department of Internal Medicine, Seoul Red Cross Hospital, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Acinetobacter baumannii;
Carbapenem resistance;
Healthcare-associated infection
- MeSH:
Acinetobacter baumannii;
Bacteria;
Bacterial Infections;
Drug Resistance, Bacterial*;
Escherichia coli;
Humans;
Intensive Care Units;
Klebsiella pneumoniae;
Pseudomonas;
Respiration, Artificial;
Retrospective Studies;
Risk Factors;
Tertiary Care Centers*
- From:The Ewha Medical Journal
2013;36(2):126-131
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: Since the 1990s, drug-resistant bacteria have become common pathogens of hospital-acquired infections. In recent years, healthcare-associated infections have come to the fore, and it is reported that distribution rates of these bacteria are comparable to those of hospital-acquired infections. However, there have been few studies on differences in resistant bacteria depending on the size of hospitals. Thus, the authors studied differences in drug-resistant bacteria between a tertiary hospital and smaller medical institutions. METHODS: We retrospectively analyzed the clinical findings and sputum culture results of patients transferred from tertiary hospitals (group A, n=74) and those transferred from smaller medical institutions (group B, n=65). RESULTS: The number of patients with malignancy was higher in group A than in group B. The length of intensive care unit stay was longer in group A than in group B. Antibiotic therapy and mechanical ventilation were more frequently used in group A than in group B. There were no significant differences between the 2 groups in bacterial species (Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa) and their resistance rates to carbapenem, while there were significant differences between the 2 groups in the bacterial species (Acinetobacter baumannii) and its resistance rate to carbapenem. CONCLUSION: In this study, there were significant differences between the 2 groups in the bacterial species and resistance rates to carbapenem for A. baumannii infection unlike other bacterial infections. Further studies on risk factors and patient classification are needed to confirm our results.
